The bill modifies existing provisions regarding the sale of cannabinoids derived from hemp in Minnesota. It allows individuals selling edible cannabinoids to convert their registration to a comparable hemp license and introduces new regulations for hemp-derived topical products. Key amendments include the stipulation that products containing nonintoxicating cannabinoids must not exceed 0.3 percent tetrahydrocannabinol and cannot be sold to individuals under 21 years of age. Additionally, the bill specifies that products intended for external use must not be consumed through combustion, vaporization, or injection, with exceptions for sublingual applications.

Furthermore, the bill adds new requirements for lower-potency hemp edible manufacturers, mandating compliance with state and local building codes and ensuring sanitary conditions. It also updates labeling requirements for hemp-derived topical products, removing the option to provide certain information via scannable barcodes. The prohibitions section reinforces that products cannot be marketed for medical purposes or contain unsafe additives, and it reiterates the age restriction for cannabinoid products. Overall, the bill aims to enhance the regulatory framework surrounding hemp-derived products while ensuring consumer safety.

Statutes affected:
Introduction: 151.72, 342.45, 342.63, 342.66